Tag: platform

OSLO, Norway (8 August 2025) – TGS, a leading provider of energy data and intelligence, is pleased to announce the award of a streamer acquisition contract in the East Mediterranean. Acquisition is scheduled to commence in Q3 this year and the contract has a duration of approximately 30 days.

MOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its upsized initial public offering of 16,666,667 shares of its common stock at a public offering price of $19.00 per share. All of the shares of common stock are being offered by Heartflow. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Heartflow, are expected to be approximately $316.7 million. In addition, Heartflow has granted the underwriters a 30-day option to purchase up to an additional 2,500,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on August 8, 2025 under the ticker symbol "HTFL.” The closing of the offering is expected to occur on August 11, 2025, subject to the satisfaction of customary closing conditions.

FARMINGDALE, NY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Innovative Warehouse Solutions (IWS), a leading U.S.-based third-party logistics (3PL) provider, is proud to announce a strategic partnership with Passport, a premier international shipping carrier. This collaboration enhances IWS's capabilities to offer clients streamlined global distribution through Delivered Duty Paid (DDP) and Delivered Duty Unpaid (DDU) services. With this new alliance, IWS clients can now reach customers in over 180 countries via DDP, simplifying and accelerating cross-border e-commerce fulfillment like never before.

ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced financial results for the quarter ended June 30, 2025, and provided an update on its Symphony IL-6 test program and key operational milestones.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Annual Recurring Revenue (ARR)⁽¹⁾ up 55% YoY to $79.6 million
Total Revenue up 47% YoY to $23.9 million
Adjusted EBITDA⁽¹⁾ up 50% YoY to $6.3 million

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES